Remove 2009 Remove Biomarkers Remove Technology
article thumbnail

APOE4 & Cardiovascular Risk

Dr. Paddy Barrett

2009 Apr;29(4):431-8. Identification of a new plasma biomarker of Alzheimer's disease using metabolomics technology. [link] 8 Goldstein JL, Brown MS. The LDL receptor. Arterioscler Thromb Vasc Biol. doi: 10.1161/ATVBAHA.108.179564. 108.179564. PMID: 19299327; PMCID: PMC2740366. J Lipid Res. 2012 Mar;53(3):567-576.

article thumbnail

The legal case – naming a few names

Dr. Malcolm Kendrick

(2022-25) Swiss Reinsurance Company: £645K China Kadoorie Biobank (2002-ongoing) AstraZeneca: $300K Bayer AG: £300K GlaxoSmithKline: £3.6M Elinogrel feasibility trial (2010-2011) Novartis: £500K EMPA-KIDNEY (2017-ongoing) Boehringer Ingelheim: £106.3M Establishing Fuwai-Oxford research centre (2010-ongoing) Merck: £1.1M